A panel of colorimetric assays to measure enzymatic activity in the base excision DNA repair pathway by Healing, Eleanor et al.
Nucleic Acids Research, 2019 1
doi: 10.1093/nar/gkz171
A panel of colorimetric assays to measure enzymatic
activity in the base excision DNA repair pathway
Eleanor Healing1, Clara F. Charlier2, Lisiane B. Meira2 and Ruan M. Elliott 1,*
1Department of Nutritional Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK and 2Department of
Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey GU2 7XH, UK
Received October 19, 2018; Revised February 13, 2019; Editorial Decision March 04, 2019; Accepted March 07, 2019
ABSTRACT
DNA repair is essential for the maintenance of ge-
nomic integrity, and evidence suggest that inter-
individual variation in DNA repair efficiency may
contribute to disease risk. However, robust assays
suitable for quantitative determination of DNA re-
pair capacity in large cohort and clinical trials are
needed to evaluate these apparent associations fully.
We describe here a set of microplate-based oligonu-
cleotide assays for high-throughput, non-radioactive
and quantitative determination of repair enzyme ac-
tivity at individual steps and over multiple steps of
the DNA base excision repair pathway. The assays
are highly sensitive: using HepG2 nuclear extract,
enzyme activities were quantifiable at concentrations
of 0.0002 to 0.181 g per reaction, depending on the
enzyme being measured. Assay coefficients of varia-
tion are comparable with other microplate-based as-
says. The assay format requires no specialist equip-
ment and has the potential to be extended for analy-
sis of a wide range of DNA repair enzyme activities.
As such, these assays hold considerable promise for
gaining new mechanistic insights into how DNA re-
pair is related to individual genetics, disease status
or progression and other environmental factors and
investigating whether DNA repair activities can be
used a biomarker of disease risk.
INTRODUCTION
There are sevenmajorDNArepair pathways in human cells,
each with capacity to repair specific lesion types, and effec-
tive functioning of these is critical for cellular survival and
health (1,2). Among these, the base excision repair (BER)
pathway is responsible for repairing damage caused to sin-
gle bases by insults such as reactive oxygen species, ioniz-
ing radiation and alkylating agents (3). BER can also repair
apurinic/apyrimidinic (AP) sites and single strand breaks
(SSB) in the DNA backbone (4). If repairing a base lesion,
the first step in the BER pathway is performed by a DNA
glycosylase that removes the damaged base. A total of 11
DNA glycosylases have been characterized in mammalian
systems to date, each specific for a particular set of the base
lesions (5). Uracil DNA glycosylases (UDGs) preferentially
remove uracil in DNA that has occurred by spontaneous
deamination of cytosine (generating U:G mispairs) or that
has been misincorporated during DNA synthesis (leading
to U:A base pairs) (6,7). UDGs remove the damaged base
and leave an AP site, which is a substrate for AP endonucle-
ase (APE1). APE1 cleaves the DNA sugar-phosphate back-
bone at the AP site (8), leaving a one-nucleotide gap with a
hydroxyl group at the free 3′ DNA strand end and a de-
oxyribose phosphate group (dRP) attached to the 5′ DNA
strand terminus. Following APE1 incision, BER can pro-
ceed as either short-patch BER or long-patch BER. For
both pathways, a polymerase acts upon the one-nucleotide
gap, most commonly DNA polymerase  (POLB), adding
one undamaged base in short patch BER and using its dRP
lyase activity to remove the 5′ dRP from the DNA back-
bone at the repair site (9). Alternatively, more than one nu-
cleotide is replaced via long-patch BER (10) with the result-
ing displaced DNA strand being excised by flap endonucle-
ase (FEN1) (11). The final step in both short and long patch
BER is the rejoining of the DNA backbone by either DNA
ligase IIIa or DNA ligase I (12,13).
A reduction in BER activity or its dyscoordination can
lead to a range of detrimental health outcomes, the most
common being increased susceptibility to cancer, neurode-
generation and premature aging (14). In the general popula-
tion, BER enzyme activity has been found to vary by up to
10-fold among apparently healthy individuals (15). In some
cases, such variation may influence disease risk. For exam-
ple, familial adenomatous polyposis colon cancer is asso-
ciated with a mutation of the DNA repair enzyme MYH
adenine DNA glycosylase (16), and sporadic lung cancer
may be linked to reduced 8-oxoguanine DNA glycosylase
(OGG1) activity (17). Conversely, an increase in BER ca-
pacity is not necessarily protective against cancer, as shown
by an increase in lung cancer risk with increased alkyl ade-
nine glycosylase (AAG) activity (18). It is clear that the as-
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sociation of BER capacity with health outcomes is a com-
plex issue and one that requires further research.
While a range of methods have been used to measure
DNA repair capacity, most present critical limitations such
as low sensitivity, low throughput or the requirement for
radio-labeling. Here, we describe the development and val-
idation of a panel of non-radioactive assays that can deter-
mine DNA repair activities within the BER pathway in a
high-throughput fashion. All the assays employ the same
core strategy, whereby a hairpin loop oligonucleotide sub-
strate is covalently bound by one end to wells of 96-well
plates (Supplementary Figure S1). Each oligonucleotide
complex carries a single internal lesion within the double-
stranded region of the hairpin loop that is representative
of a lesion or intermediate in the BER pathway. A fluo-
rescein moiety is incorporated at the opposite end of the
oligonucleotide structure to that bound to the wells of the
plate. Purified recombinant DNA repair enzymes or repair
enzymes present in nuclear extracts act on the substrate, ei-
ther creating or removing an SSB or an AP site in the com-
plex. During the subsequent denaturation step, the end of
the oligonucleotide carrying fluorescein will be lost from
the wells of the plate if the oligonucleotide hairpin struc-
ture contains an SSB. If alkaline denaturation is used, AP
sites are converted to SSB and the same effect is achieved.
Consequently, enzyme activity is determined by quantify-
ing the amount of fluorescein retained in (or eluted from)
the wells as a result of the denaturation step.
These new assays have a number of key advantages;
they are sensitive, high throughput, fully quantitative, cost-
effective, non-radioactive and can quantitate each individ-
ual step of BER. In addition to step-specific analyses, we
demonstrate that the assay format can also be used to quan-
tify overall repair across multiple steps of BER. Therefore,
we propose that our assays are uniquely suited for investiga-
tions of DNA repair capacity as a potential health-related
biomarker.
MATERIALS AND METHODS
Reagents
All chemicals were purchased from Sigma-Aldrich (Dorset,
UK), unless otherwise specified. Nunc® Immobiliser™
amino 96-well plates and Halt™ protease inhibitor cock-
tail were purchased from ThermoFisher Scientific (Hemel
Hemstead, UK). Synthetic oligonucleotides were pur-
chased from Integrated DNA Technologies (Leuven, Bel-
gium) and Sigma-Aldrich, and were purified by high-
performance liquid chromatography. Recombinant T4
DNA ligase, 3′ → 5′ exonuclease minus Klenow fragment
of Escherichia coli DNA polymerase I (exo− Klenow), de-
oxynucleotide triphosphates (dNTPs) and herring sperm
DNA were purchased from Promega (Southampton, UK).
Recombinant human POLB (19), purified by his-tag chro-
matography using an imidazole gradient elution (20), was
a generous gift from Dr Jason Parsons (University of Liv-
erpool, UK). All other recombinant DNA repair enzymes
and uracil glycosylase inhibitor (UGI) were purchased from
New England Biolabs (Hitchin, UK). L189 mammalian
DNA ligase inhibitor was purchased from Bio-Techne
(Abingdon, UK). Cell lines were purchased from ATCC
(Middlesex, UK) and cell culture consumables were pur-
chased from Lonza (Slough, UK). SV40 T-antigen trans-
formed wild-type MEFs were a generous gift from Prof.
Leona D. Samson (MIT, USA).
Cell culture
The human HepG2 hepatocellular carcinoma (21), Caco-
2 colorectal adenocarcinoma (22), ARPE-19 retinal pig-
mented epithelium and bothwild-type andPolB null 88TAg
immortalized mouse embryonic fibroblast (MEF) (23) de-
rived cell lines were cultured in Dulbecco’sModified Eagle’s
Medium (DMEM) containing 25 mM glucose, and supple-
mentedwith 10% v/v fetal bovine serum, 100 units/ml peni-
cillin, 100 units/ml streptomycin, 2 mM L-glutamine and
1× non-essential amino acids. AAG knockout ARPE-19
cells were generated using an AAG-specific CRISPR/Cas9
Knockout (KO) Plasmid system obtained from Santa Cruz
Biotechnology (Dallas, TX,USA) followingmanufacturer’s
protocols. Cells were incubated in a humidified atmosphere
at 37◦C with 5% carbon dioxide and harvested at approx-
imately 80% confluence. Harvested cell pellets were stored
at −80◦C prior to nuclear extraction and protein quantifi-
cation.
Immunoblotting
Cells were lysed with M-PER Mammalian Protein Extrac-
tion Reagent ThermoFisher (Hemel Hemstead, UK), sup-
plemented with 1× Halt protease inhibitor cocktail Ther-
moFisher (Hemel Hemstead, UK). Protein concentration
was determined using the BCA assay (Pierce). Total pro-
tein lysates (20 g) were separated under denaturing con-
ditions in Any kD Mini-Protean TGX (BioRad, USA)
gels. Proteins were then transferred onto polyvinylidene
difluoride membranes (BioRad, USA). Membranes were
blocked in 1% non-fat milk and incubated overnight at 4◦C
with anti--actin (1:7000 dilution; ab52614, Abcam) and
anti-AAG (1:500 dilution; HPA006531, Sigma-Aldrich) an-
tibodies. After primary antibody incubation, membranes
were washed and then incubated with the secondary an-
tibodies IRDye 680RD green goat anti-rabbit IgG and
IRDye 800CW red goat anti-mouse IgM (LI-COR Bio-
sciences, Lincoln, USA) at 1:10 000 for 1 h at room tem-
perature. Proteins were detected using the Odyssey CLx IR
imaging system (LI-COR Biosciences, Lincoln, USA).
Peripheral blood mononuclear cell isolation
Ethical permission for this workwas obtained from theUni-
versity of Surrey Ethics Committee prior to the start of
the study. All volunteers provided written informed con-
sent and all aspects of the work were performed in accor-
dance with the principle of the Declaration of Helsinki.
Each volunteer provided a single blood sample of 20 to 50
ml obtained by venepuncture of an antecubital vein. The
blood was collected into vacutainers containing potassium
ethylenediaminetetraacetic acid (EDTA) anticoagulant. Pe-
ripheral blood mononuclear cells (PBMCs) were isolated
using the Optiprep™ method as described previously (24).
The PBMC pellets were snap frozen and stored at −80◦C
for subsequent extraction.
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Nuclear extraction and protein quantification of samples
Nuclear extraction was carried out on each cell pellet using
a nuclear and cytoplasmic extraction reagents (NE-PER)
kit (Thermo Fisher Scientific, Hemel Hemstead, UK) ac-
cording to the manufacturer’s instructions, with the addi-
tion of 1× Halt™ protease inhibitor cocktail to the extrac-
tion reagents. The protein concentration of each nuclear ex-
tract was quantified using a microBCA kit (ThermoFisher
Scientific, Hemel Hemstead, UK) according to manufac-
turer’s instructions. Nuclear extracts were frozen in aliquots
at −80◦C before thawing for DNA repair enzyme activity
assays.
Oligonucleotide-based assay for quantifying DNA repair en-
zyme activity
Substrate preparation. For all experiments, the initial
oligonucleotide (URA03, HX02, AP02, Contr01, GAP04,
LIG03 or HX02; sequence information provided in Table
1) was diluted from 10 M stock solutions into freshly pre-
pared 0.1 M bicarbonate buffer (pH 9.6) to a final con-
centration of 0.5 nM, and 100 l of this solution was
incubated in the wells of Nunc® Immobiliser™ amino
96-well plates (Thermo Fisher Scientific, Hemel Hem-
stead, UK) overnight at 4◦C. Plates were then washed
with phosphate-buffered saline containing 0.1% v/v Tween-
20 (PBST) and 100 l of a 0.5 nM solution of the
appropriate complementary oligonucleotide (Loop01Aflc
or Loop01Gflc for URA03; Loop01Aflc, Loop01Cflc,
Loop01Gflc or Loop01Tflc; Loop01A for AP02, HX02 or
Contr01; Loop02 for LIG03 or GAP04; sequence informa-
tion provided in Table 1) was added following dilution in
hybridization buffer (6× saline sodium citrate (SSC) buffer,
5 mM EDTA, 0.1% v/v Tween-20). Each plate was then
sealed and heated to 95◦C for 10 min in a hybridization
oven, followed by gradual cooling to 80◦C, maintenance at
80◦C for 10 min, and then further gradual cooling to 21◦C.
Uracil DNA glycosylase activity assay. To measure UDG
activity, plates containing URA03 annealed to Loop01Aflc
or Loop01Gflc were treated with 0.05U T4 DNA ligase in
100 l of T4 DNA ligase buffer (30 mM Tris–HCl, pH 7.8,
30 mMNaCl, 10 mMMgCl2, 10 mM dithiothreitol (DTT),
1 mM ATP) for 1 h at 37◦C. The plates were then heated to
65◦C for a further 15 min and the hot liquid immediately
decanted from the wells. Fresh DNA ligase buffer (100 l)
was added to each well and the plate heated to 65◦C for
a further 15 min, the liquid immediately decanted and the
wells washed three times with PBST. This process produces
a hairpin loop structure containing a single uracil lesion in
a U:A base pair (with Loop01Aflc) or U:G base mismatch
(with Loop01Gflc) within the double-stranded region. For
the assays, the substrate was then incubated for 1 h at 37◦C
with varying concentrations of recombinant UDG or ap-
propriate concentrations of nuclear extract sample, both in
DNA repair buffer (20 mM Tris–HCl, pH 7.8, 100 mM
NaCl, 0.4 mM EDTA, 3.4% v/v glycerol, 0.4 mM DTT, 2
mM MgCl2, 1 g/ml herring sperm DNA). Following the
repair incubation, the contents of the wells were decanted
and the wells washed three times with PBST. A volume of
150 l of alkaline buffer (0.1× SSC, 0.1 M NaOH) was
added to the wells and the contents of the plate heated to
95◦C for 10 min. The liquid was then decanted from the
wells and the alkaline denaturation step repeated oncemore
prior to three PBST washes. For the analysis of UDG in-
hibition by UGI, repair reactions were performed as de-
scribed above using a fixed amount of either recombinant
UDG or HepG2 nuclear extract in the presence of varying
amounts of UGI. The amount of UDG or nuclear extract
used for the inhibition assays was selected to achieve UDG
activity in the wells toward the high activity end of the near
linear portion of the UDG standard curve.
AP site incision activity assay. To measure AP site inci-
sion activity, substrate was prepared as for the UDG as-
say except that oligonucleotide AP02, containing an inter-
nal tetrahydrofuran (THF) group acting as an AP site ana-
log, was bound to the plate and then hybridized and lig-
ated to Loop01Aflc. This substrate was incubated with dif-
ferent concentrations of recombinant APE1 enzyme or nu-
clear extract samples in DNA repair buffer for 1 h at 37◦C
before denaturation as above except that neutral buffer
(0.1× SSC buffer containing 0.1% w/v sodium dodecyl sul-
phate) was used in place of the alkaline buffer. To deter-
mine whether AP site incision activity was affected by the
nucleotide opposite the THF, oligonucleotide Loop01Aflc
was replaced with Loop01Cflc, Loop01Gflc or Loop01Tflc
in some assays. To assess the effects of the APE1 inhibitor
methoxyamine, immobilized substrate containing a single
AP site was prepared by incubation of the UDG assay
oligonucleotide complex with excess recombinant UDG
(0.2 U/well) for 1 h at 37◦C. This substrate was then incu-
bated for 30min with varying concentrations of methoxam-
ine in PBS prior to performing the AP site incision assay as
described above.
DNA polymerase activity assay. The substrate for the
DNA polymerase assay was prepared by coupling oligonu-
cleotide GAP04 to the plate and then hybridizing oligonu-
cleotide Loop02 to it, to produce a double-stranded sub-
strate containing a hairpin loop and a single nucleotide gap.
DNApolymerase activity was determined by incubating the
substrate with either various concentrations of recombinant
exo− Klenow or nuclear extract sample in the DNA repair
buffer to which was added 2 mM ATP, 30 M of each of
dATP, dCTP, dGTP and dTTP plus an excess (0.05 U/100
l) of T4 DNA ligase. Reactions were incubated for 1 h at
37◦C. Denaturation was then achieved as described for the
UDG assay.
DNA ligase activity assay. The substrate for the DNA lig-
ase assay was prepared by coupling oligonucleotide LIG03
to the plate and then hybridizing oligonucleotide Loop02 to
it to produce a double-stranded substrate containing a hair-
pin loop with a ligatable nick in the sugar-phosphate back-
bone. DNA ligase activity was determined by incubating
this substrate with varying concentrations of either recom-
binant T4 DNA ligase or nuclear extract sample in DNA
repair buffer containing 2 mM ATP and a final concentra-
tion of 10 mM MgCl2 for 1 h at 37◦C. Denaturation was
then achieved as described for the UDG assay.
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Table 1. Sequences of oligonucleotides used in experiments
Name Sequence (5′→3′) Internal lesiona Substrate for:
URA03 (P)CACGAA(U)CAACTCAGCAACTCCt
t(NH2)b,c,d,e
Uracil (U) UDG
HX02 (P)CACGAA(X)CAACTCAGCAACTCCt
t(NH2)f
Hypoxanthine (X) AAG
AP02 (P)CACGAA(B)CAACTCAGCAACTCCt
t(NH2)g
Tetrahydrofuran (B) AP incision
Contr01 (P)CACGAATCAACTCAGCAACTCC
tt(NH2)
n/a n/a
GAP04 (P)CAACTCAGCAACTCCtt(NH2) Single nucleotide gap DNA polymerase
LIG03 (P)TCAACTCAGCAACTCCtt(NH2) Ligatable SSB DNA ligase
Loop01Aflc (flc)ttGGAGTTGCTGAGTTGATTCGTG
AGCACCAACCGGTGCTh
n/a n/a
Loop01Aird (ird)ttGGAGTTGCTGAGTTGATTCGTG
AGCACCAACCGGTGCTi
n/a n/a
Loop01Cflc (flc)ttGGAGTTGCTGAGTTGCTTCGTG
AGCACCAACCGGTGCT
n/a n/a
Loop01Gflc (flc)ttGGAGTTGCTGAGTTGGTTCGTG
AGCACCAACCGGTGCT
n/a n/a
Loop01Tflc (flc)ttGGAGTTGCTGAGTTGTTTCGTG
AGCACCAACCGGTGCT
n/a n/a
Loop02 (flc)ttGGAGTTGCTGAGTTGATTCGTG
AGCACCAACCGGTGCTCACGAA
n/a n/a
aInternal lesion present in oligonucleotide or in final substrate complex.
bP indicates phosphorylation.
cNH2 indicates amino modifier group.
dU indicates uracil.
elower case letters indicate nucleotides linked via phosphorothiate bonds.
fX indicates hypoxanthine.
gB indicates tetrahydrofuran.
hflc indicates fluorescein.
iird indicates IRDye®.
To investigate the effects of the mammalian DNA lig-
ase specific inhibitor L189 (25), repair reactions were per-
formed as described above using a fixed amount of either
recombinant UDG or HepG2 nuclear extract in the pres-
ence of varying amounts of L189. A 10 mM stock solution
of L189 in DMSO was used to prepare the serial dilutions
(the highest final DMSO concentration was 1% v/v). A set
of control reactions were set up containing DMSO at fi-
nal concentrations equivalent to those in the reactions con-
taining L189 to account for possible effects of the vehicle.
The cell extracts were incubated for 10 min at 25◦C with
the varying concentrations of L189 or vehicle before being
cooled on ice again and then added to the assay plate wells.
Total AP site and DNA polymerase/dRP lyase assays. The
substrate for these assays was prepared by treatment of the
immobilized ligated URA03/Loop01Aflc substrate with
excess UDG (0.2U/well) for 1 h at 37◦C, as described for
the methoxyamine inhibition assays, to generate a substrate
containing an AP site. To measure complete AP site repair
activity, this substrate was incubated with varying concen-
trations of nuclear extract in DNA repair buffer containing
2 mM ATP and 30 M of each of dATP, dCTP, dGTP and
dTTP and a final concentration of 10 mMMgCl2. To deter-
mine DNA polymerase/dRP lyase activity, an excess (0.05
U/well) of T4 DNA ligase was also included in each reac-
tion mix. Denaturation was then achieved as described for
the UDG assay except for one set of control wells, to which
no nuclear extract had been added during the repair incu-
bation, which were subjected to neutral rather than alkaline
denaturation.
Alkyl adenine DNA glycosylase assay. AAG activity was
determined in the same way as the UDG assay except that
in place of URA03 an oligonucleotide (HX02) containing a
single hypoxanthine was coupled to the surface of the plate
and the repair reactions were performed with either recom-
binant human AAG or nuclear extract in 20 mM Tris (pH
7.5), 100 mM KCl, 5 mM EDTA, 1 mM EGTA, 5 mM -
mercaptoethanol, 1g/ml herring sperm DNA.
Colorimetric detection of fluorescein. After the final denat-
uration step of each assay, fluorescein retained in the wells
of the plates was quantified by colorimetric detection. Each
well was incubated with anti-fluorescein antibody conju-
gated with horseradish peroxidase (HRP) (Abcam ab6656,
Cambridge, UK) diluted 10 000-fold in PBST/1% w/v
bovine serum albumin for 1 h at 21◦C. The liquid was
decanted from the wells and the wells washed four times
with PBST. TMBMicrowell Peroxidase Substrate for HRP
(KPL, Wembley, UK) was then added (100 l/well) and
plates incubated at 21◦C for 30min. Reactions were stopped
by the addition of 100 l 1 M phosphoric acid to each well.
Absorbance was read at 450 nm using an Omega Fluostar
microplate reader (BMG Labtech, Aylesbury, UK).
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Characterization of oligonucleotides eluted from the plates
after repair incubation for the UDG and APE1 assays
Oligonucleotide substrates attached to the wells on Nunc
Immobilizer plates were prepared for the UDG and AP
site incision assays as described above except that the
oligonucleotide concentrations used were increased from
0.5 to 25 nM and oligonucleotide Loop01Aird (carrying
an IRDye® 800CW modification in place of the fluo-
rescein at the 5′ end) was used in place of Loop01Aflc.
For each of the two assays, all 96 wells on one plate
were treated as replicates and incubated with nuclear ex-
tract (3 g/well Caco-2 extract for the UDG assay or
50 ng/well HepG2 nuclear extract for the AP site inci-
sion assays, respectively) for 2 h at 37◦C under the as-
say conditions described above. The material eluted during
the subsequent denaturation step was collected and pooled
for all the replicate wells. The eluted oligonucleotide solu-
tions were concentrated at 4◦C using Vivapin 15R centrifu-
gal ultrafiltration units with a 2 kDa nominal molecular
weight cutoff (Sartorius, Epsom, UK). The concentrated
samples were extracted with phenol:chloroform:isoamyl al-
cohol (25:24:1) and the aqueous phase then diafiltered
into 20 mM Tris–HCl, 1 mM DTT, 1 mM EDTA (pH
8) and further concentrated using Vivaspin 500 centrifu-
gal ultrafiltration units with a 3 kDa nominal molecular
weight cutoff. The oligonucleotide samples eluted from the
plates, unligated Loop01Aird, Loop01Aird ligated in so-
lution to URA03, the product obtained after incubation
of the in-solution ligated URA03-Loop01Aird with the re-
combinant E. coli UDG, and oligonucleotide length stan-
dard ladder (Integrated DNA Technologies, Leuven, Bel-
gium) were electrophoresed through 15% polyacrylamide-
urea gels, stained with and visualized using a LI-COR
Odyssey® CLx imaging system to visualize all IRDye®
800CW labeled oligonucleotides and a LI-COR Odyssey
Fc imaging system (LI-COR Biotechnology, Cambridge,
UK) to visualize the position of IRDye® 800CW labeled
oligonucleotides in relation to Sybr Green stained oligonu-
cleotide length standard ladder.
Data analysis
Data are presented as mean± SD of at least three technical
replicates unless otherwise stated. For theDNApolymerase
and DNA ligase assays, data were background corrected by
subtraction of the mean value obtained for the zero recom-
binant enzyme controls. Background corrected absorbance
values were normalized to the maximum absorbance value
of the assay standard curve. Nuclear extract enzyme activ-
ities were determined by interpolation from the recombi-
nant enzyme standard curve, fitted with y = (Ae−Bx) + C
for UDG, APE1 and AAG datasets, or y = A(1-e−Bx) for
DNA polymerase and DNA ligase datasets. The parame-
ter E0.KCat/KM was determined from time course data for
the recombinant repair enzymes UDG, APE1 and AAG
as the parameter B from the non-linear regression analyses
performed using the equations above and KCat/KM deter-
mined based on the individual enzyme concentrations (E0)
calculated from specific activity data provided by the sup-
plier. Lower limits of detection for the assays were calcu-
lated by interpolation of the activity corresponding to the
mean− 2× SD of the absorbance for the zero enzyme con-
trols of the UDG and APE1 standard curves or mean + 2
× SD of the absorbance for the zero enzyme controls of the
exo− Klenow fragment andT4DNA ligase standard curves.
Intra- and inter-assay coefficients of variation (CV) were
calculated based on apparent enzyme activities, interpo-
lated from recombinant enzyme standard curves, for quality
control nuclear extracts prepared from HepG2 or Caco-2
cells. For the inhibitor analyses, IC50 values were estimated
using the log(inhibitor) versus response curve fitting func-
tion in GraphPad Prism 7.0, and the effects of UGI, L189
and methoxyamine on other DNA repair enzyme activities
were investigated by two-tailed one-way analysis of vari-
ance. Unpaired two-tailed t-tests were used to compare the
BER enzyme activities in wild-type versus PolB null MEF
and HepG2 versus Caco-2 cell line nuclear extracts. Spear-
man correlation analysis was performed with two-tailed P
values calculated to examine the association between en-
zyme activities at individual steps of BER in the PBMC nu-
clear extracts.
RESULTS
Synthetic oligonucleotides immobilized inmicroplate well can
be used to measure the activity of individual enzymes in the
base excision repair pathway
For each assay, a synthetic oligonucleotide complex bearing
a single modified base or lesion representative of an inter-
mediate in the BER pathway was attached to the surface
of a microplate (Supplementary Figure S1). First, a single
oligonucleotide was covalently attached, via an aminomod-
ification at its 3′ end, to the surface of wells in Nunc® Im-
mobiliser™ amino 96-well plates. A second oligonucleotide,
complementary to the first in the region of its 5′ end, with
a hairpin loop structure at its 3′ end and a fluorescein
moiety at the 5′ terminus was then hybridized to the first.
The oligonucleotides were designed such that there was a
two nucleotide ‘spacer’, composed of nucleotides joined by
phosphorothiate bonds, between the NH2 group and the
first base of the double-stranded section of the oligonu-
cleotide complex. In the case of the UDG, AP site inci-
sion, AAG and DNA ligase assays, the oligonucleotides
used form an immobilized double-stranded hairpin loop
complex with a ligatable single strand nick between the 5′
end of the first oligonucleotide bound to the plate and the
3′ end of the second hybridized to the first. For the DNA
ligase assay, this formed the final assay substrate. For the
UDG, AP site incision and AAG assays, the nick was lig-
ated by the incubation with excess T4 DNA ligase to gener-
ate intact hairpin loop structures. Note that we found that
coupling of pre-hybridized and ligated complex to the wells
resulted in unacceptably high background signal whereas
in-well hybridization and ligation following coupling of the
first oligonucleotide to the wells overcame this issue.
The UDG substrate formed contains a single uracil with
an adenine or guanine opposite on the complementary
strand depending on whether oligonucleotide Loop01Aflc
or Loop01Gflc was used. The AP site incision substrate
formed contains a single AP site analog with an adenine, cy-
tosine, guanine or thymine opposite on the complementary
strand depending on whether oligonucleotide Loop01Aflc,
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Loop01Cflc, Loop01Gflc or Loop01Tflc was used. For the
AAG assay, the substrate formed contains a single hypox-
anthine:thymine base pair. In the case of the DNA poly-
merase assay, the structure was essentially identical to that
used for the DNA ligase assay except that there was a sin-
gle nucleotide gap between the 5′ end on the first oligonu-
cleotide and the 3′ end of the second.
The hairpin loop structure was incorporated into the as-
say substrate design for two reasons. First, following the
ligation of the two oligonucleotides used to generate the
UDG, AP site incision and AAG substrates, it is impor-
tant to remove any unligated complexes, which could con-
found assay results if ligases present in the nuclear extracts
acted on these complexes during the repair incubation step.
The differential between the melting temperature of the un-
ligated complex and the ligated hairpin structure is greater
than it would be for an equivalent linear double-stranded
complex melting temperature, making removal of the unli-
gated oligonucleotide without denaturing the ligated com-
plex easier. Second, the loop structure reduces the number
of free strand ends accessible to degradation by non-specific
exonucleases that could be present in cell extracts. As an ad-
ditional protection against exonucleases, phosphorothioate
linkages were incorporated between the three terminal nu-
cleotides at the 3′ end of the oligonucleotides attached to
the well surface and at the 5′ ends of the oligonucleotides
hybridized to those attached directly to the wells.
Preliminary experiments were performed using a range of
oligonucleotide concentrations to determine the minimum
amounts that would provide adequate signal. Direct fluo-
rescence detection of the fluorescein retained in the wells
required an initial oligonucleotide concentration of≥5 nM,
whereas robust colorimetric detection of the fluorescein re-
tained in the wells based on the use of HRP-conjugated
anti-fluorescein antibody could be achieved with much
lower oligonucleotide concentrations (≤0.5 nM) (data not
shown). Based on this observation, the colorimetric detec-
tion system was used routinely in subsequent experiments.
Uracil DNA glycosylase activity. Due to our particular re-
search interest in the effects of uracil misincorporation re-
sulting from aberrant one carbon metabolism, we started
the validation work for this assay using an oligonucleotide
substrate containing an U:A base pair before going on vali-
date it also for substrate containing an U:G mismatch, rep-
resentative of the lesion arising from cytosine deamination.
In initial experiments, performed with a substrate contain-
ing an U:A base pair, UDG activity in HepG2 nuclear ex-
tract proved difficult to detect, while the activity of recom-
binant E. coli UDG was readily detected. In some, but not
all, experiments it appeared that there was a small decrease
in signal with increasing nuclear extract concentration at
the lower end of the range tested (typically in the range 0–
0.5 g/well) but at higher extract concentrations the UDG
activity appeared to be progressively inhibited (data not
shown). This led us to hypothesize that other nuclear pro-
teins present in the extract were binding to the DNA and
blocking access of the UDG to the lesion site. In support of
this hypothesis, we found addition of excess recombinant
E. coliUDG after incubation with higher concentrations of
nuclear extract failed to excise the uracil and create alkali
labile AP sites. In an attempt to counteract possible inhibi-
tion by non-specific binding of other nuclear proteins to the
assay substrate, herring spermDNAwas added to the repair
incubations to act as competitor forDNA-binding proteins.
The presence of herring spermDNA in the reaction mix did
not interfere with the action of recombinant UDG, whereas
its inclusion dramatically increased the apparent UDG ac-
tivity in the nuclear extract (Supplementary Figure S2). For
some of the other assays described below, in which lower
concentrations of nuclear extract (<0.5 g/well) were used,
addition of herring sperm was not strictly required. How-
ever, for consistency, herring sperm DNA was included in
all assays.
When incubated with either the U:A base pair or U:G
mismatch containing oligonucleotide substrates, recombi-
nant E. coliUDG generated AP sites in the oligonucleotide
substrate in a concentration-dependent manner as evi-
denced by the production of alkali-labile sites converted to
strand breaks during the subsequent alkaline denaturation
step, and so decreased retention of fluorescein-conjugated
oligonucleotide detectable in the wells (Figure 1A). The en-
zyme acted approximately 5-fold more efficiently on the
U:G containing substrate, consistent with the known sub-
strate preferences of the family-1 UDGs (7). The parameter
KCat/KM, variously referred to as the specificity constant,
the performance constant or the enzymatic proficiency (26),
was determined by non-linear regression analysis of time
course data generated for E. coliUDG acting on both sub-
strates (Figure 1B). KCat/KM was estimated at 0.01 nM−1
s−1 for the substrate containing an U:G mismatch and as
0.002 nM−1 s−1 for the substrate containing an U:A base
pair. Values of KCat/KM for E. Coli UDG we identified
or derived from previously published work varied 500-fold
from 0.0002 to 0.1 nM−1 s−1 (27–31), albeit with 4 of the 6
values falling in the range 0.01–0.06. Thus the values deter-
mined with our new assay format fall within, or close to, the
central range of published estimates.
In the presence of herring sperm DNA, the expected
concentration-dependent decrease in signal was observed
with increasing amounts of HepG2 nuclear extract (Fig-
ure 1C) and PBMC nuclear extract (Figure 1D) for both
the U:A and U:G containing substrate. As with the recom-
binant enzyme, both nuclear extracts excised uracil 4- to
6-fold more efficiently from the U:G containing substrate
than the U:A containing substrate. For both the U:A and
U:G substrates, the apparent absolute level ofUDGactivity
in the pooled PBMC nuclear extract was approximately 7-
fold lower than in the HepG2 nuclear extract. The apparent
UDG activities in the HepG2 and PBMC nuclear extracts,
determined by interpolation from the standard curve gener-
ated by the action of recombinant E. coli UDG on the rel-
evant U:A or U:G containing substrate, were directly pro-
portional to the amount of nuclear extract added over the
entire range tested (0–4 g/well for the HepG2 extract and
0–10 g/well for the PBMC extract) (Figure 1E and F).
To confirm that the concentration-dependent signal re-
duction produced by the nuclear extract was specifically due
to the excision of the uracil only, and not to non-specific
degradation of the oligonucleotide substrate, a control sub-
strate lacking any internal uracil or other DNAdamage was
incubated under the same conditions with recombinant E.
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Figure 1. Effect of uracil DNA glycosylase activity on oligonucleotide substrates containing a single U:A base pair or U:G mismatch. Incubation with
recombinant Escherichia coli uracil DNA glycosylase led to enzyme concentration dependent (A) and time-dependent (B) decreases in the amount of intact
U:A (open symbols) and U:G (closed symbols) containing substrate retained in the wells after alkaline denaturation. For the time course analysis squares,
circles and triangles indicate data generated with 0.1, 0.2 or 0.4 units/well, respectively, for the U:A containing substrate or with 0.0125, 0.025 or 0.05
units/well, respectively, for the U:G containing substrate. Incubation with HepG2 nuclear extract (C) or peripheral blood mononuclear cell pooled extract
(D) also caused concentration-dependent decreases in the amount of intact U:A and U:G containing substrate retained in the wells. For both substrates,
the apparent uracil DNA glycosylase activity was directly proportional to the concentration of HepG2 (E) and peripheral blood mononuclear cell (F)
nuclear extract over the entire range tested (r2 = 0.99 in both cases). Data shown represent the mean ± SD of triplicate technical replicates except for time
course data for which duplicates were analyzed.
coli UDG or HepG2 nuclear extract. Under these condi-
tions, neither the recombinant UDG preparation nor the
nuclear extract decreased the signal when incubated with
the control substrate in contrast to the effect on uracil-
containing substrate (Supplementary Figure S3).Moreover,
gel electrophoretic analysis was used to characterize thema-
terial eluted during the denaturation step of theUDGassay.
This demonstrated the eluate contained a unique detectable
oligonucleotide that differed in size from Loop01Aird or
Loop01Aird ligated to URA03 but co-migrated, as ex-
pected, with the fluorophore-labeled oligonucleotide pro-
duced when Loop01Aird hybridized and ligated to URA03
in solutionwas incubatedwithE. coliUDGand then heated
under alkaline conditions to convert AP sites into SSB
(Supplementary Figure S4).
We further evaluated the specificity of this assay by in-
vestigating the effects of the UDG specific inhibitor UGI
from bacteriophage PBS2 (32). Inclusion of UGI in the re-
pair incubations with the substrate containing an U:A pair
caused concentration-dependent inhibition of UDG activ-
ity with an IC50 of 0.002 U/well for both the recombinant
E. coli UDG and the UDG activity in HepG2 nuclear ex-
tract (Supplementary Figure S5A). In contrast, UGI at con-
centrations up to 2 U/well had no significant effect on the
activity of other DNA repair enzymes in the HepG2 nu-
clear extract analyzed using theAP site incision,DNApoly-
merase or DNA ligase assays described below (Supplemen-
tary Figure S5B–D). Mammalian cells can express up to
four known UDGs; UNG (with variant form UNG1 lo-
calized within mitochondria and UNG2 localized within
the nucleus), TDG, SMUG1 andMBD4 (7). Of these, UGI
only inhibits UNG1 and 2. Since different cell types have
unique expression profiles of these differentUDGs,we com-
pared the effects of UGI on apparent UDG activity in
HepG2 versus PBMC nuclear extracts. UGI, at 2U per re-
action, reduced the apparent UDG activity by 85–100% for
both cell extracts with both assay substrates (Supplemen-
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tary Figure S5E) indicating that UNG2 is the predominant
activity detected with this assay for both cell types.
AP site incision activity. AP site incision activity was mea-
sured using a substrate containing a single THF, a syn-
thetic AP site analog commonly used for research pur-
poses (33,34). The THF was positioned at the same loca-
tion in the oligonucleotide substrate as the uracil in the
UDG substrate. Recombinant human APE1 acted on this
substrate to produce strand nicks leading to concentration-
and time-dependent decreases in the amount of intact THF-
containing oligonucleotide bearing a 3′ fluorescein follow-
ing neutral denaturation (Figure 2A and B). Based on the
time course analysis, KCat/KM for the purified recombi-
nant APE1 was estimated at 0.05 nM−1 s−1. Estimates of
KCat/KM for APE1 derived from previous publications, we
identified (35–44) varied approximately 50-fold from 0.026
(42) to 1.2 nM−1 s−1 (43). However, 5 of the 9 estimates were
within the range 0.026–0.050 nM−1 s−1, in good agreement
with the estimate of KCat/KM, we obtained.
HepG2 and PBMC nuclear extracts also elicited
concentration-dependent decreases in the amount of intact
substrate retained in the wells (Figure 2C and D). AP
site incision activity in the nuclear extracts was directly
proportional to the amount of extract added in the range
0–0.02 g/well for the HepG2 nuclear extract (Figure
2E) and 0–0.0125 g/well for the PBMC nuclear extract
(Figure 2F). Gel electrophoretic analysis of material eluted
during the denaturation step confirmed that incubation
of the substrate with HepG2 nuclear extract led to the
release of a unique oligonucleotide that co-migrated with
the oligonucleotide eluted during the denaturation step of
UDG assay (Supplementary Figure S4).
We also evaluated the effect of the nucleotide opposite
the THF lesion by comparing the AP site incision activities
of recombinant APE1 andHepG2 nuclear extract acting on
oligonucleotide substrates generated by hybridizing and lig-
ating Loo01Aflc, Loop01Cflc, Loop01Gflc or Loop01Tflc
to AP02 immobilized in the assay plate wells. Using this ap-
proach, we found that recombinant APE1 had essentially
identical incision activity regardless of the nucleotide lo-
cated opposite the THF (Supplementary Figure S6A). This
observation is in line with the generalized function of APE1
to act at any AP site and with previous characterization of
this enzyme (45). The HepG2 nuclear extract also exhibited
similar AP site incision activity regardless of the type of nu-
cleotide opposite the THF (Supplementary Figure S6B).
To our knowledge, there is currently no rigorously vali-
dated high specificity competitive inhibitor available for AP
site incision activity of APE1, the major mammalian AP
site endonuclease. However, methyoxyamine acts as a non-
competitive inhibitor of APE1 by chemically modifying AP
sites to a form that APE1 acts on much less efficiently
(46). Therefore, we investigated the effects ofmethoxyamine
pre-treatment of a substrate containing an AP site (gener-
ated by UDG treatment of the uracil containing substrate)
on the AP site incision activity HepG2 nuclear extract.
Pre-treatment with methoxyamine led to a concentration-
dependent decrease in the degree of strand incision achieved
when 4 ng/well HepG2 nuclear extract was used (Supple-
mentary Figure S7A). The IC50 value estimated for this in-
hibitory action was 1.4 mM and no AP site incision activ-
ity was detectable when the substrate was pre-treated with
methoxyamine concentrations of 5mMor higher. However,
incubation with 1 g/well of the HepG2 nuclear extract in
wells pre-treated with 25 mM methoxyamine led to a sim-
ilar extent of substrate incision to that observed with 4 ng
of HepG2 nuclear extract in the absence of methoxyamine
pre-treatment (data not shown), consistent either with the
reported ability of APE1 to act on methoxyamine modified
AP sites at much reduced efficiency (47) or with the pres-
ence, at lower levels, of other enzymes capable of AP inci-
sion at methoxyamine modified AP sites in the extract.
Methoxyamine (25 nM) pre-treatment of the substrate
for the UDG assay or the AP site incision assay substrate,
containing the THF AP site analog, had no effect on the
apparent UDG and AP site incision activity of HepG2 nu-
clear extract (Supplementary Figure S7B and C). On the
other hand, methoxyamine (25 nM) pre-treatment of the
substrates for the DNA polymerase and DNA ligase assays,
described below, led to a moderate (approximately 25–50%)
reduction in the enzyme activities detected in HepG2 nu-
clear extract using these two assays (Supplementary Figure
S7D and E). These observations suggest that, at high con-
centrations, methoxyamine reacts weakly with substrates
containing a single strand break to partially inhibit the
strand ligation and perhaps the gap filling step but with in-
tact oligonucleotide substrates it only reacts with natural
abasic sites to create a form that is much more resistant to
AP site incision.
DNA polymerase activity. To determine the activity of
DNA polymerases in nuclear extracts capable of working
on single-nucleotide gaps with processed DNA backbone
ends, the substrate prepared was identical to that used in
the assays described above but with a single nucleotide gap
at the same position in the sequence as the uracil and THF
used for the UDG and AP site incision assays. This assay
requires not only the action of DNA polymerase to fill the
gap, but also DNA ligase to seal the single strand break,
so that enzyme activity is detected as an increase in intact
oligonucleotide carrying the 3′ fluorescein moiety follow-
ing the repair reaction and subsequent denaturation step.
Therefore, excess T4 DNA ligase was added to all reac-
tions to ensure that the polymerase activity was rate lim-
iting. A standard curve, constructed using serial dilutions
of recombinant exo− Klenow fragment, produced the ex-
pected concentration-dependent increase in signal (Figure
3A). Incubation of the substrate with HepG2 or PBMC nu-
clear extract also produced a concentration-dependent in-
crease in signal (Figure 3B andC). The apparentDNApoly-
merase activity in the nuclear extracts, based on interpola-
tion from the standard curve produced using exo− Klenow,
was directly proportional to the amount of extract added in
the range 0–0.06 g/well for HepG2 nuclear extract and 0–
0.25 g/well for pooled PBMC nuclear extract (Figure 3D
and E). In the absence of dNTPs or ATP from the reaction
mix, no repair activity was detected with the exo− Klenow
or with nuclear extracts (data not shown). Thus, omitting
dNTPs and ATP from the reaction mixes for the DNA gly-
cosylase and AP site incision assays avoids potential con-
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Figure 2. Effect of apurinic/apyrimidinic (AP) site incision activity on an oligonucleotide substrate containing a single tetrahydrofuran AP site analog.
Incubation with recombinant humanAPE1 led to enzyme concentration-dependent (A) and time-dependent (B) decreases in the amount of intact substrate
retained in the wells after neutral denaturation. For the time course analysis squares, circles and triangles indicate data generated with 0.1, 0.2 or 0.4
units/well, respectively. Incubation with HepG2 nuclear extract (C) or PBMC pooled nuclear extract (D) also caused concentration-dependent decreases
in the amount of intact substrate retained in thewells. The apparentAP site incision activity was directly proportional to the concentration of nuclear extract
over the range 0–0.02 g/well for the HepG2 nuclear extract (r2 = 0.99) (E) and over the range 0–0.0125 g/well for the peripheral blood mononuclear
cell nuclear extract (r2 = 0.95) (F). Data shown represent the mean ± SD of triplicate technical replicates except for time course data for which duplicates
were analyzed.
founding of these assays by the action of DNA polymerases
or DNA ligases in the nuclear extract.
DNA ligase activity. The substrate prepared for the DNA
ligase assay was identical to that used in the DNA poly-
merase assay except that an additional nucleotide (T) was
included at the 5′ end of the oligonucleotide attached via
its 3′ end directly to the surface of the wells to generate an
oligonucleotide complex containing a single ligatable nick
Serial dilutions of recombinant T4 DNA ligase were used
to generate the standard curve (Figure 4A). Again, incu-
bation of the substrate with HepG2 or pooled PBMC nu-
clear extract produced a concentration-dependent increase
in signal (Figure 4B and C). The apparent DNA ligase ac-
tivity in the nuclear extracts, based on interpolation from
the standard curve produced using T4 DNA ligase, was di-
rectly proportional to the amount of extract added in the
range 0–0.5 g/well for HepG2 nuclear extract, and 0–0.63
g/well for pooled PBMC nuclear extract (Figure 4D and
E). As with the DNA polymerase assays, no repair activ-
ity was detected with the DNA ligase assay when ATP was
omitted from the repair reactions. Moreover, inclusion of
L189, a specific inhibitor of mammalian DNA ligases I, III
and IV (25), inhibited theDNA ligase activity inHepG2 nu-
clear extract in a concentration-dependent manner with an
IC50 of 14M(Supplementary Figure S8A), very similar to
the previously published IC50 values of 5Mfor bothDNA
ligases I and IV and 9 M for DNA ligase III, determined
using the individual purified enzymes (25). In contrast, T4
DNA ligase was much less sensitive to the presence of L189.
At concentrations below 100 M L189 had no significant
effects of T4 DNA ligase activity and even at 100 and 200
M, the highest concentrations tested, L189 only reduced
activity to 89%and 84%of control values, respectively. L189
at a concentration of 200 M had no significant effect on
the BER activities of HepG2 nuclear extract measured us-
ing the UDG, AP site incision or DNA polymerase assays
(Supplementary Figure S8B–D).
Assay sensitivity and reproducibility. The lower limits of
detection for each of the single repair step assays described
above were estimated based on the standard curves as ex-
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Figure 3. Assay for DNA polymerase repair activity. Incubation of an immobilized hairpin loop oligonucleotide substrate containing a single nucleotide
gap on one strand within the double-stranded region with exonuclease minus Klenow fragment of Escherichia coli DNA polymerase I, in the presence
of dNTPs, ATP and excess T4 DNA ligase, led to an increase in intact substrate retained in the microplate wells following neutral denaturation that was
dependent on the concentration of the polymerase (A). Incubation with HepG2 nuclear extract (B) or peripheral blood mononuclear cell pooled nuclear
extract (C) also caused concentration-dependent increases in the amount of intact substrate retained in the wells. The apparent DNA polymerase activity
was directly proportional to the concentration of nuclear extract over the range 0–0.06 g/well for the HepG2 nuclear extract (r2 = 0.98) (D) and over the
range 0–0.25 g/well for the peripheral blood mononuclear cell nuclear extract (r2 = 0.99) (E). Data shown represent the mean± SD of triplicate technical
replicates.
plained in the methods section, and the minimum amount
of HepG2 nuclear protein needed to detect activity was
found using the lower limit of detection for each enzyme.
The intra- and inter-assay coefficients of variation (CV)
were determined by repeat analyses of nuclear extract qual-
ity control samples (Table 2). These analyses demonstrate
that all four assays are highly sensitive and give good re-
producibility, with intra-assay CVs generally <10% and
inter-assayCVs generally<15%. Taken together, our results
demonstrate that we have generated a sensitive and repro-
ducible panel of microplate-based assays that are capable of
measuring each enzymatically controlled step of the BER
pathway.
We next used these assays to compare BER enzyme activ-
ities in two different cells lines (HepG2 and Caco-2) using
sets of nuclear extracts from each cell type that had been
isolated over serial culture passages. The analyses demon-
strated generally consistent levels of UDG, AP site incision,
DNA polymerase and DNA ligase activity within each cell
type but notable differences between the two cell lines (Fig-
ure 5). While the activity of AP site incision activity did
not differ significantly between the two cell types, appar-
ent UDG activity was 1.7-fold higher in Caco-2 cells than
in HepG2 (P < 0.0005) whereas the DNA polymerase and
DNA ligase activities were 2.0 and 3.8-fold lower, respec-
tively, in Caco-2 cells than HepG2 (P < 0.0005 for DNA
polymerase and P < 0.05 for DNA ligase). These data in-
dicate that BER enzyme activities are relatively stable over
time within each of these cells lines, that consistent activ-
ities can be obtained with the nuclear extraction protocol
and that the assays can be used to distinguish cell-specific
profiles of BER enzyme activities.
A key goal of this work was to develop assays suitable for
use with samples collected from clinical studies. To evaluate
this, we performed a pilot analysis of DNA repair enzyme
activities in individual PBMC nuclear extracts derived from
13 apparently healthy volunteers (9 females and 4 males,
aged 22–50). UDG, AP site incision, DNA polymerase and
DNA ligase activities were quantified in PBMC nuclear ex-
tracts from each individual. Based on the observation of
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Figure 4. Assay for DNA ligase activity. Incubation of an immobilized hairpin loop oligonucleotide substrate containing a single ligatable nick in one
strand within the double-stranded region with T4 DNA ligase, in the presence of ATP, led to an increase in intact substrate retained in the microplate wells
following neutral denaturation that was dependent on the concentration of the polymerase (A). Incubation with HepG2 nuclear extract (B) and peripheral
blood mononuclear cell pooled nuclear extract (C) also caused concentration-dependent increases in the amount of intact substrate retained in the wells.
The apparent DNA ligase activity was directly proportional to the concentration of HepG2 (D) and PBMC (E) nuclear extract over the range 0–0.5g/well
for the HepG2 nuclear extract (r2 = 0.99) and over the range 0–0.63 g/well for the peripheral blood mononuclear cell nuclear extract (r2 = 0.99). Data
shown represent the mean ± SD of triplicate technical replicates.
Table 2. Sensitivity and reproducibility of DNA repair enzyme activity assays
Assay Lower LoD (U/well)a Amount of NE (ng/well)b Intra-assay CV (%)c Inter-assay CV (%)d
1000 18 ± 3 18
UDG (U:A)e 0.009 2000 10 ± 2 10
3000 8 ± 2 6
UDG (U:G)6 0.006 nd nd nd
2 28 ± 11 8
AP site incision 0.005 4 14 ± 3 13
8 12 ± 4 12
12.5 12 ± 4 15
DNA polymerase 8 × 10−7 25 5 ± 1 9
50 9 ± 3 6
100 5 ± 1 6
DNA ligase 2 × 10−6 200 5 ± 2 10
200 10 ± 4 20
aLower limit of detection (LoD) calculated by interpolating enzyme activity for mean absorbance at 0U enzyme minus 2 × SD for uracil DNA glycosylase
(UDG) and AP site incision assays, or mean absorbance at 0U enzyme plus 2 × SD for DNA polymerase and DNA ligase assays.
bAmounts of nuclear extract (NE) used for determinations of assay coefficients of variation (CV).
cMean ± SD of intra-assay CV based on four individual analyses each of eight technical replicates.
dInter-assay CV calculated from assays performed on four independent plates.
eSensitivity and reproducibility of UDG assay measuring excision of uracil from a substrate containing an U:A base pair.
fSensitivity of UDG assay measuring excision of uracil from a substrate containing an U:G mismatch. A HepG2 NE quality control sample was used for
all assay CV determinations with the exception of UDG, for which a Caco-2 NE quality control sample was used.
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Figure 5. Within and between cell line variability in DNA repair enzyme activity of HepG2 and Caco-2 cells. (A) Uracil DNA glycosylase activity was
higher in Caco-2 nuclear extract than HepG2 nuclear extract. (B) No significant differences were found in apurinic/apyrimidinic site incision activity
between the two cell lines. (C) DNA polymerase activity was lower in Caco-2 nuclear extract than HepG2 nuclear extract. (D) DNA ligase activity was
lower in Caco-2 nuclear extract than HepG2 nuclear extract. Bars indicate mean ± SD of six independent replicates. The symbols * and *** indicate
significant differences between the enzyme activities of the cell lines at P < 0.05 and P < 0.001, respectively (based on two-tailed unpaired t-tests).
lower UDG activity detected when using the substrate con-
taining an U:A base pair, the substrate containing an U:G
base pair was used for the UDG assay of these samples.
In line with previous reports, there was substantial inter-
individual variation of the BER enzyme activities, ranging
from 3.6-fold to 6.3-fold differences frommaximum tomin-
imum activities across the 13 volunteers for AP site incision
and DNA ligase, respectively (15). Interestingly, there was
also clear evidence of correlations between the activities of
the different enzymes with statistically significant associa-
tion betweenUDGandAP site incision activities (r= 0.703,
P < 0.01), UDG and DNA ligase activities (r = 0.753, P
< 0.005), AP site incision and DNA ligase activities (r =
0.786, P < 0.005) and DNA polymerase and DNA ligase
activities (r= 0.725, P< 0.01) (Figure 6). This suggests that
the activity of these different BER enzyme may be coordi-
nated. However, these data are from a small pilot study, and
analysis of samples from amuch larger cohort is required to
confirm these associations.
Total AP site repair and DNA polymerase/dRP lyase assays.
In addition to use for analyzing repair enzyme activities at
individual steps of BER, this assay format has the poten-
tial to be used to determine combined enzyme activity over
multiple steps in BER. We tested this using the AP site as a
starting point since this is a common stage in the repair of
many lesions processed via BER (3). The substrate for these
assays was generated by treating the U:A base pair contain-
ing UDG assay substrate with excess recombinant E. coli
UDGwithin the wells of the plates to generate immobilized
hairpin oligonucleotides containing a single AP site. This
strategy was favored over use of the substrate for the AP site
incision assay because while the THF moiety incorporated
as an AP site analog is acted upon by APE1, the 5′ blocking
group left behind cannot be excised by POLB (48). There-
fore, we would predict that repair of the substrate contain-
ing the THF lesion could not proceed via short patch BER.
Complete repair of the AP site generated from the
URA03/Loop01Aflc complex should lead to incorporation
of a deoxythymidine at the lesion site and the resultant re-
paired complex will be resistant to alkaline denaturation.
Since this is a multi-step repair process, a standard curve
cannot be generated using serial dilutions of a single recom-
binant enzyme in the same way as for the assays described
above. However, by mixing oligonucleotides URA03 and
Contr01 in different ratios prior to coupling the oligonu-
cleotide mixtures to the microplate wells, we were able to
generate hairpin loop structures with Loop01Aflc that con-
tained varying proportions of uracil lesions and were then
able to demonstrate that the color developed following
treatment of these with excess UDG and subsequent alka-
line denaturation was directly proportional to the amount
of substrate retained in the wells (Figure 7A). Thus, by in-
cluding control wells in the complete AP site repair assay
that were treated with no cell extract and then subjected ei-
ther to alkaline or neutral denaturation we are able to deter-
mine the signal equivalent to zero and 100% repair, respec-
tively, and from this interpolate percentage repair achieved
with different amounts of nuclear extract.
With this assay format, a concentration-dependent in-
crease in percentage repair of the AP site-containing sub-
strate was observed using HepG2 nuclear extract ranging
from 0 to 1g/well (Figure 7B).We hypothesized, given the
very high levels of AP site incision activity determined in the
cell extracts, that incision at the AP site would not be a rate-
determining step in this assay. In support of this we found
that the extent of repair completed was almost identical re-
gardless of whether or not the AP site-containing substrate
was treated with excess recombinant APE1 prior to repair
incubation with 0.4 g/well HepG2 nuclear extract (Figure
7C). Moreover, the extent of repair was essentially identi-
cal regardless of whether a mixture of all four dNTPs (30
M each) was included in the repair incubation or 30 M
of only dTTP, suggesting that short patch repair predomi-
nated (Figure 7D). Given these observations, one or more
of the three other steps (gap filling by a DNA polymerase,
removal of the 5′ dRP group by a dRP lyase and strand
ligation) must determine the overall percentage repair ob-
served. Therefore, we produced a variant of this assay in
which excess T4 DNA ligase was included in the repair re-
actions. Additional T4 DNA ligase was initially tested at
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Figure 6. Base excision repair enzyme activity is correlated between some, but not all, enzymes of the pathway in nuclear extracts of peripheral blood
mononuclear cells from different individuals. (A) Uracil DNA glycosylase (UDG) activity was positively correlated with apurinic/apyrimidinic (AP) site
incision activity (r = 0.61, P < 0.05). (B) UDG activity was not significantly correlated with DNA polymerase activity (r = 0.58, P = 0.053). (C) UDG
activity was positively correlated with DNA ligase activity (r = 0.81, P < 0.001). (D) AP site incision activity was not significantly correlated with DNA
polymerase activity (r = 0.40, P = 0.177). (E) AP site incision activity was positively correlated with DNA ligase activity (r = 0.73, P < 0.01). (F) DNA
polymerase activity was positively correlated with DNA ligase activity (r = 0.67, P < 0.05).
concentrations of 0.005 and 0.05 U/reaction on the basis
that these were sufficient to drive the reaction to completion
over 1 h in the DNA ligase assay (Figure 4A). We observed
almost identical enhancement of the extent of complete AP
site repair with both concentrations (data not shown), con-
firming that these T4DNA ligase concentrations were suffi-
cient to ensure the maximal effect. A more detailed analysis
using the higher of these two T4DNA ligase concentrations
showed that the extent of repair was increased by approx-
imately 8–12% compared with the assay performed in the
absence of added T4 DNA ligase, depending on the con-
centration of nuclear extract used (Figure 7B). We propose
that this format provides an assay specific for the combined
gap filling DNA polymerase and dRP lyase activities of ex-
tracts.
When a substrate containing the THFAP site analog was
used in place of an AP site generated by the action of UDG
on a uracil containing oligonucleotide complex, repair of
the substrate was achieved by the nuclear extract when a
mixture of the four dNTPs was included in the repair re-
action although the extent of repair was lower, at approxi-
mately 55% of that observed when a substrate containing a
normal AP site was used (Figure 7D). Moreover, unlike the
repair of a substrate containing a normal AP site, inclusion
of dTTP as the only deoxynucleotide in the repair mixture
was not sufficient to support any detectable repair of the
THF-containing substrate (Figure 7D). This indicates that,
as predicted, short patch repair cannot be completed using
the THF containing AP site analog but that it can be re-
paired via an alternative process, which is mostly likely long
patch BER.
To investigate the specificity of the assays for DNA poly-
merase, combined DNA polymerase/dRP lyase and com-
plete repair of the substrate containing a THF AP site ana-
log, we compared the activity detected with each assay us-
ing nuclear extracts prepared from wild-type and PolB null
MEFs. Activity detected with all three assays was substan-
tially lower in the PolB null nuclear extracts than in the
wild-type samples (Supplementary Figure S9A–C), whereas
UDGactivity was 2-fold higher inPolB null extracts than in
WT extracts (Supplementary Figure S9D). AP site incision
and DNA ligase activities of the wild-type and PolB null
cells were very similar (Supplementary Figure S9E and F).
For the DNA polymerase assay, there was a 45-fold differ-
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Figure 7. Complete repair of an apurinic/apyrimidinic (AP) site or a tetrahydrofuran AP site analog by HepG2 nuclear extract. The data presented in (A)
demonstrate that color development observed in the assay plate wells is directly proportional to the amount of fluoresceinmodified oligonucleotide retained
in thewells (r2 = 0.99). These datawere generated by (i) coating thewells of aNunc® Immobilizer™ plate with 0.5 pmol/well ofmixtures containing varying
proportions of oligonucleotides URA03 (containing a single uracil lesion) and Contr01 (lesion free control), (ii) hybridizing and ligating a complementary
oligonucleotide (Loop01Aflc) to the immobilized URA03/Contr01 mixtures to form intact hairpin loop structures covalently attached to the plate at the 3′
endwith a fluoresceinmoiety at the 5′ end, (iii) incubating the immobilized substrates with excessEscherichia coli uracil DNAglycosylase to excise the uracil
from those oligonucleotide carrying them to createAP sites, (iv) subjecting the substrate to hot alkaline denaturation to convert all AP sites into single strand
breaks and remove any oligonucleotides released as a result and (v) detecting fluorescein retained in the wells using anti-fluorescein horseradish peroxidase
conjugate and TMB substrate. Based on this observation, percentage repair was determined by linear interpolation from the absorbance values for 0 and
100% repair control wells. (B) Effects of varying concentrations of HepG2 nuclear extract on the extent of complete AP site repair in the absence (open
circles) and presence (closed circles) of excess T4 DNA ligase. (C) Comparison of extent of complete repair by HepG2 nuclear extract of an oligonucleotide
complex containing an AP site that had either been pre-treated or not with excess recombinant human AP endonuclease 1. (D) Comparison of the extent
of complete repair of an oligonucleotide containing either a normal AP site (black bars) or the tetrahydrofuran AP site analog (white bars) by 800 or 400
ng/well of HepG2 nuclear extract in the presence of either 30 M of all four deoxynucleotides (dATP, dCTP, dGTP and dTTP) or only 30 M dTTP.
Error bars indicate mean ± SD of triplicate technical replicates.
ence between wild-type andPolB null extracts (P< 0.0001).
For the combined DNA polymerase/dRP lyase assay, there
was 56-fold difference (P < 0.0001). For the assay deter-
mining complete repair of the substrate containing a THF
AP site analog, there was a 9-fold difference (P < 0.0001).
However, for the last of these assays the repair activity deter-
mined with the highest concentration of PolB null nuclear
extract tested (2g/well) remained below the limit of detec-
tion. Thus, while there is clearly a striking difference in the
capacity of wild-type and PolB null MEF nuclear extracts
to repair the THF AP site analog, the apparent fold differ-
ence in activitymay not be as accurate as the fold differences
determined with the other two assays.
Finally, we evaluated the capacity of purified recom-
binant human POLB to rectify the repair deficiencies of
PolB null extract observed using each of these three as-
says. In each case, addition of POLB was sufficient to com-
plement the extract activity such that repair similar to, or
even exceeding, that of the wild-type MEF extract could be
achieved (Supplementary Figure S9G–I).
Alkyl adenine DNA glycosylase activity assay. Having
demonstrated that the assay format can be used for each
individual step in the BER of uracil lesions, we also eval-
uated the feasibility of extending the assay format to the
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repair of another base lesion by a different DNA glyco-
sylase. The modified base hypoxanthine can be formed in
DNA by the spontaneous deamination of adenine. This le-
sion is excised by AAG (49). Therefore, we prepared a hair-
pin loop oligonucleotide immobilized in assay plates that
contained a single hypoxanthine (referred to as inosine (I)
in the form of the deoxynucleoside), in an I:T base pair,
as the substrate for the AAG assay. Incubation of this sub-
strate with recombinant human AAG led to concentration-
and time-dependent production of alkali-labile sites as evi-
denced by the reduction of fluorescein retained in the wells
following the alkaline denaturation step (Figure 8A and B).
From the time course analysis, KCat/KM was estimated at
2.8 × 10−4 nM−1 s−1. This compares with KCat/KM values
for AAG derived from previous publications we identified
(49–54), where the substrates used contained I:T base pairs,
which varied more than 400-fold from 2.4 × 10−5 (54) to
0.01 nM−1 s−1 (50) but with 4 of the 6 estimates in the much
narrower range of 2.4× 10−5 to 6.4× 10−4 nM−1.s−1. Thus,
here again, the estimate we obtained for KCat/KM with the
new assay format aligned well with the majority of previous
estimates of this parameter.
Incubation of the I:T containing substrate with
HepG2 or pooled PBMC nuclear extract also led to
a concentration-dependent reduction in signal (Figure
8C and D). The apparent AAG activity in the nuclear
extracts, based on interpolation from the standard curve
produced recombinant AAG, was directly proportional to
the amount of extract added in the range 0–10 g /well
(Figure 8E and F).
To evaluate the specificity of this assay for AAG, we com-
pared the AAG expression and apparent AAG activity in
nuclear extract from ARPE19 cells (wild-type for AAG)
with that in three different clonal AAG knockout cell lines
derived from the parental cell line. AAG protein was de-
tected by western blot analysis in extract prepared from the
originalARPE19 cells line but not in any of the three knock-
out cell lines (Supplementary Figure S10A). The apparent
activity in each of the knockout cell lines was very low; well
below the assay limit of detectionwhereasAAGactivity was
readily detectable in the cells expressing AAG (Supplemen-
tary Figure S10B) while UDG activities were similar across
all the cell lines (Supplementary Figure S10C).
DISCUSSION
Development of a robust method for the measurement of BER
enzyme activity
The work described here details the development and val-
idation of a panel of assays for quantifying enzyme activ-
ity at each individual step in the BER pathway. We have
demonstrated that these assays can be used to determine
DNA repair enzyme activity not just with purified recombi-
nant enzymes but also within the complex matrix of mam-
malian cell extracts, and that the quantities of extract re-
quired for the analysis are sufficiently small that enough
material for detailed analysis can be obtained even where
the amount of starting material is limited, such as with
blood samples from human volunteers. Moreover, the re-
producibility of the data generated is comparable with other
microplate assays such as ELISAs.
When evaluating the estimates of KCat/KM obtained us-
ing the new assay format for the recombinant BER enzymes
E. coli UDG, human APE1 and human AAG, we noted
substantial variation in the range of published values. The
scale of this variation has been commented on previously
(55) and sources of the variation are likely to include the
assay format, the reaction conditions, whether a single or
double-stranded substrate was used, for double-stranded
substrates the type of nucleotide opposite the lesion and
the overall sequence context of the lesion (27,30,31,53,55).
However, for all of three enzymes the majority of published
values fall within considerably tighter ranges and the values
we have derived are within, or very close to, the these esti-
mates. This supports the concept that these DNA repair en-
zymes are able to act on the immobilised oligonucleotides in
a similar fashion to oligonucleotide substrates in solution.
We also demonstrated the specificity of the new assays via
a combination of different approaches. Using an oligonu-
cleotide with no internal lesions, we confirmed that the
nuclear extracts do not non-specifically degrade the im-
mobilized oligonucleotide substrate but that they do act
upon oligonucleotide substrates containing a single uracil
or THFAP site analog to release a substrate fragment of the
expected size following the denaturation step. The family-1
UDG inhibitor UGI was shown to inhibit the activity of
both recombinant E. coli UDG and the UDG activity of
HepG2 nuclear extract with a very similar IC50 but had no
detectable effect on the HepG2 nuclear repair activities de-
tected using any of the other single step specific repair as-
says. UNG is the mammalian representative of the family-
1 UDGs and is expressed in two variant forms: UNG1 is
localized to mitochondria and UNG2 is localized to nu-
clei (7,56). Thus our analysis suggests that the UDG assay
detected primarily UNG2 in both the HepG2 and PBMC
nuclear extracts. This is further supported by the observa-
tion that the recombinant E. coli UDG and the UDG ac-
tivities present in the both nuclear extracts exhibited a sim-
ilar moderate preference for substrate containing an U:G
mismatch over substrate containing a U:A base pair (57).
Furthermore UNG2 has been reported to be the predomi-
nant UDG found in the nuclei of proliferating mammalian
cells but UNG2 expression has been found to be lower in
non-proliferative cells (57) and in leukocytes and PBMC
preparations (57,58). This aligns with our observation of
substantially lower UDG activity in the PBMC nuclear ex-
tract compared with the HepG2 nuclear extract.
Methoxyamine pre-treatment of substrate containing an
AP site dramatically reduced AP site incision by HepG2
nuclear extract with an IC50 of 1.4 mM. However, AP site
incision was readily detectable when the concentration of
HepG2 nuclear extract was increased by 200-fold above
that normally required for the assay even when the sub-
strate had been pre-treated with 25 mM methoxyamine.
While this does not conclusively confirm that the predom-
inant AP incision activity being detected using this assay
with nuclear extracts is APE1, these observations are en-
tirely consistent with that situation since APE1 is an abun-
dant ubiquitously expressed enzyme that has been reported
to account for nearly all of the AP site incision activity
observed in cell extracts (59) and its activity on AP sites
is dramatically reduced (approximately 330-fold), but not
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Figure 8. Assay for alkyladenine DNA glycosylase (AAG) activity. Incubation with recombinant human AAG led to enzyme concentration- (A) and
time-dependent (B) decreases in the amount of intact oligonucleotide substrate containing an I:T base pair following alkaline denaturation. For the time
course analysis squares, circles and triangles indicate data generated with 0.1, 0.2 or 0.4 units/well, respectively. Incubation with HepG2 nuclear extract
(C) or peripheral blood mononuclear cell pooled extract (D) also caused concentration-dependent decreases in the amount of intact substrate retained in
the wells. The apparent AAG activity was directly proportional to the sample concentration over the range 0–10 g/well for HepG2 (E) and peripheral
blood mononuclear cell (F) nuclear extracts (r2 = 0.94 in both cases). Data shown represent the mean± SD of triplicate technical replicates except for time
course data for which duplicates were analyzed.
completely blocked, by methoxyamine modification of AP
sites (47). We observed that pre-treatment of the substrate
for the UDG assay or of the substrate for the AP site in-
cision assay containing the THF AP site analog had no
effect supporting the specificity of the reaction between
methoxyamine and normal AP sites in DNA. However, as
far as we are aware the observation that very high levels of
methoxyamine weakly interacted with substrates contain-
ing a single strand nick to partially inhibit DNA ligation
and/or gap filling is novel.
The specificity of theDNA ligase assaywas demonstrated
by the fact that the assays requires a substrate containing a
single ligatable nick (the presence of a single nucleotide gap
at the nick completely blocked ligation unless the appropri-
ate dNTP was also included), that the reaction is ATP de-
pendent and that the apparent DNA ligase activity detected
in HepG2 nuclear extract was inhibited by L189 whereas
L189 had only a marginal effect on the activity of T4 DNA
ligase and no detectable activity on UDG, AP site inci-
sion orDNApolymerase activity inHepG2 nuclear extract.
Based on the evidence presented, it is not possible to ascer-
tain exactly which DNA ligase (I, III or IV) is primarily re-
sponsible for the activity detected. This could be elucidated
by the use of other specific inhibitory compounds such as
L67 and L87 (25) or through the use of cells deficient for
each specific ligase.
The latter approach was demonstrated with the AAG as-
say, the specificity of which was confirmed by the absence
of any detectable AAG activity in AAG null ARPE19 cells.
Equally, comparison of BER activities in wild-type and
PolB null MEF nuclear extracts demonstrated that the ab-
sence of POLB dramatically reduced the activity detected
with the all three of the new assays that require DNA poly-
merase gap filling activity. Both wild-type and PolB null
MEF cell lines grow and divide rapidly and the nuclear
extracts should contain significant replicative DNA poly-
merase activity. Therefore, the very low levels of activity
detected in the PolB null nuclear extracts when using the
DNA polymerase and combined polymerase/dRP lyase as-
says suggests that both assays discriminate effectively be-
tween the BER and replicative machinery.
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The observation that addition of purified recombinant
POLB to the PolB null extracts rectified the repair de-
ficiencies in the DNA polymerase and combined DNA
polymerase/dRP lysase assays is exactly as expected.More-
over, POLB has been proposed to play a vital role in long
patch repair to fill the first nucleotide gap before either other
DNApolymerases take over or POLB continues the synthe-
sis of the long patch in a so-called ‘hit and run’ mechanism
involving the flap endonuclease FEN1 (60,61). This is con-
sistent with the finding that PolB null MEF nuclear extracts
have extremely low capacity to repair the oligonucleotide
substrate containing a THF AP site analog while addition
of POLB to these extracts corrects this deficiency.
The amounts of nuclear extract required for each assay
provide an indication of the relative activities of the enzymes
within the extracts performing each step in BER in vitro.
This suggests that AP site incision is performed most ef-
ficiently and that the second most efficient step is the gap
filling performed primarily by POLB. The DNA ligation
step was completed with either about the same efficiency
(by HepG2 nuclear extract) or somewhat slower (by PBMC
nuclear extract) than the gap filling step and that the least
efficient steps in short patch BERwere the excision of uracil
by UDGs and the removal of the dRP lyase group from the
5′ end of the DNA at the strand incision site. The observa-
tions are in line with previous studies. For example, a previ-
ous kinetic analysis of UDG and APE1 action using molec-
ular beacon and radiolabeled cleavage assays indicated that
APE1 activity exceeds UDG activity in immortalized hu-
man cell lines (62) and the removal of a dRP blocking group
following APE1 processing, carried out predominantly by
the dRP lyase activity of POLB (63), has been suggested to
be rate limiting in repair of AP sites by BER (55). However,
more detailed analyses are required to confirm whether the
dRP lyase activity is always the rate limiting enzyme activ-
ity in different cell types and the assays described here could
be a very valuable tool to help perform such detailed kinetic
analyses.
Relative strengths of the novel assay in comparison to existing
methods
These newly developed assays add to the range of DNA re-
pair analysis methods available, each of which has its own
strengths and weaknesses. Probably, the most extensively
used format of DNA repair assay to date also employs
synthetic double-stranded oligonucleotides as the substrate;
however, these are used in solution rather than being im-
mobilized (64). Most commonly the oligonucleotide car-
rying the internal lesion is radiolabeled at its 3′ end, al-
though more recent studies have reported success in replac-
ing the radiolabel with a fluorophore (65,66). After treat-
ment with the recombinant enzymes or cell extract, the
oligonucleotides are resolved on a denaturing acrylamide
gel, and the activity of the enzymes is determined by the ap-
pearance or disappearance of shorter oligonucleotide frag-
ments representing repair intermediates. Such assays have
played a critical role in elucidating themechanisms of action
of repair enzymes, their substrate preferences and overall re-
pair processes (14). A key limitation of these assays is that
they are relatively labor intensive and so have onlymoderate
throughput capacity.
A more recent variant on this type of assay makes use
of molecular beacon oligonucleotide probes in place of the
classical linear double-stranded oligonucleotides as sub-
strates (62,67,68). These assays have the important advan-
tage that they can provide real-time kinetic readouts for the
rate of repair. These can only be applied to the early steps
in the BER pathway that produce AP sites or single strand
breaks, which destabilize the hairpin loop structure and so
reduce the quenching of the fluorophores attached to the
adjacent free ends of the molecular beacon.
Another oligonucleotide-based assay, known as theDNA
repair biochip, involves fixing oligonucleotides with spe-
cific damage sites to a microplate well in order to measure
several different glycosylase activities in cell extract in one
well, with the end point measured as fluorescence (69). The
biochip represents the most similar assay to the one pre-
sented here, with key differences being that our assay format
can also be used to measure polymerase, ligase and AP site
repair, and is quantitative due to the use of a recombinant
enzyme standard curve.
Among other DNA repair assays available, host cell re-
activation techniques represent an alternative for determin-
ing DNA repair activity in live cells, whereby cells are tran-
siently transfected with plasmid reporter constructs carry-
ing defined DNA damage, and DNA repair activity is de-
tected within cells as their ability to repair the plasmid dam-
age thereby activating or inactivating expression of the re-
porter gene (70–72). Advantages of this technique include
the ability to introduce highly defined DNA damage into
the plasmids in vitro and sensitive detection of overall re-
pair of these lesions in live cells. Plasmid DNA rapidly ac-
quires nucleosomes once transfected into mammalian cells
but there are still some questions about how representa-
tive repair DNA in the context of a constitutively expressed
plasmid gene is of DNA repair across different regions of
the mammalian genome (15). Moreover, while host cell re-
activation assays are a sensitive tool for detecting differ-
ences in cellular DNA repair capacity, they are not neces-
sarily able to elucidate the changes in specific individual re-
pair activities responsible for observed differences in overall
repair efficiency.
The assays described here share the same limitation as
other oligonucleotide-based DNA repair assays, that the
substrates do not accurately reflect the complex local 3D
structures of chromatin or the overall spatial organization
of the genome within the cell nucleus, both of which are
likely to be important in determiningDNA repair efficiency.
They also provide endpoint, rather than real-time, readout.
However, they also have a number of key advantages. These
include that the lesion in the oligonucleotide substrate is de-
fined precisely, that individual steps in the repair process can
be analyzed both separately and in combination, and that
the assay format provides high throughput (with the possi-
bility of assay automation), high sensitivity and thatwe have
demonstrated rigorously that they can provide fully quanti-
tative and reproducible determination of specific DNA re-
pair enzyme activities within the complex proteinmix of cell
extracts. Additionally, the assay format has the flexibility
to be used to determine the activity of other DNA glyco-
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sylases beyond those reported here, and potentially to en-
zyme activities in other DNA repair pathways. An impor-
tant practical advantage is that the assay described here is
that they can be performed entirely with reagents that are
readily available from commercial sources without require-
ment for any specialised equipment, other than amicroplate
reader. Additionally, we have found that the assay plates can
be stored at−20◦Cwith PBST in the wells for several weeks
after most steps in the assay protocol without appreciable
effects on the results. This further facilitates batch process-
ing. The most time consuming step of the assay is setting up
the repair incubations, which involves preparing dilutions
of the recombinant enzyme standards, quality controls and
each test sample prior to pipetting the reaction mixes into
the wells of the assay plates. Having prepared appropriate
batches of assay plates, we have found that a competent
laboratory worker can set up and complete the repair incu-
bations for four to five 96-well plates in a day. Taking into
account the blanks, standards and quality control samples
included on each plate, this means it is feasible to analyze
approximately 100–200 test samples per day depending on
whether each sample is assayed in technical triplicate or du-
plicate. Use of a robotic liquid handling system for the assay
setup would further increase the throughput capacity.
From the assay design perspective, it is worth noting that
fluorescein was included at the free 5′ end of the hairpin
loop oligonucleotide substrates, on the basis that this pro-
vided two alternative quantification strategies: direct quan-
tification of fluorescein eluted from, or retained in, the well
by fluorimetry or indirect quantification based on the use
of an anti-fluorescein antibody-HRP conjugate and colori-
metric detection using a suitable substrate for the HRP. For
some of the assays, acceptable standard curves were gener-
ated by fluorimetric detection of the fluorescein eluted fol-
lowing the final denaturation step while the retained fluo-
rescence signal proved more difficult to detect and quantify,
even when black plates were used instead of clear ones (data
not shown). Overall, we found the colorimetric detection
method to be more sensitive and reliable. We also have pre-
liminary results (not shown) that indicate similar results can
be obtained using colorimetric detection strategies with bi-
otin or digoxygenin used in place of the fluorescein. It may
be that use of other fluorophores could enhance the sensi-
tivity of the direct fluorescence detection approach and, if
so, this would further streamline the assays by removing two
steps in the protocol.
CONCLUSION
The measurement of the BER pathway in this step-wise
manner has a wide range of future applications. DNA re-
pair activity has begun to be investigated as a disease risk
predictor, and a reduction in BER capacity has been asso-
ciated with lung cancer incidence (16). This is of particular
relevance as early detection of cancers, such as lung cancer,
reduces mortality by up to 20% (73). As previously men-
tioned, the association between BER function and disease
risk is far from clear, in part due to the limitations in the
measurement of the pathway thus far. The novel assays de-
scribed here could be used in large prospective studies in
combination with other techniques such as genetic and epi-
genetic analyses, quantitative PCR and western blotting,
to investigate the molecular basis for the observed inter-
individual variation in BER enzyme activities and links be-
tween BER enzyme activity and cancer risk both on an
enzyme-by-enzyme basis and on overall repair activity pro-
files. Another important aspect to consider is the connec-
tion between BER capacity and chemotherapy resistance,
where increased BER can lead to DNA-damaging agent re-
sistance, and in this context an inhibition in BER capacity
may be desirable (74).
This new assay format would also be ideal for further
studies of repair enzyme specificity in relation to the se-
quence context of different lesions and as a robust bioas-
say format for screening candidate DNA repair enzyme in-
hibitors. Furthermore, the assays would be suitable to gen-
erate detailed datasets for mathematical modeling of flux
through the BER pathway. Experiments could then be per-
formed to investigate the effect of altering the rate limiting
step on the build-up of intermediates, and overall pathway
completion. Using these approaches, the most effective tar-
gets for drug and lifestyle interventions to improve, or in-
deed reduce, BER capacity can be investigated.
The panel of assays presented here provides an exciting
opportunity to further explore various aspects of BER, in-
cluding disease prediction, modulation of the pathway and
interaction of BER with disease states.
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